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Abstract Human growth hormone (hGH), whose main func-
tion is the somatic growth stimulation, induces diverse e¡ects
including lactation. We examined the possibility of hGH stabi-
lization by elimination of its lactogenic activity. Chimeric GHs
were constructed by replacement of di¡erent segments of hGH
with sequences derived from non-lactogenic porcine GH. As was
observed in the rat Nb2-11C lymphoma cell test, lactogenic
activity of some chimeric hormones was seriously destroyed.
This kind of hormones displayed the substantial increase in
thermal and guanidine hydrochloride stability. The more stable
hGH variants were found to be more soluble in Escherichia coli
cells. ) 2002 Published by Elsevier Science B.V. on behalf of
the Federation of European Biochemical Societies.
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1. Introduction
Human growth hormone (hGH, somatotropin) is a single
chain polypeptide hormone consisting of 191 residues with
two disul¢de bonds. Its main function is the stimulation of
somatic and bone growth, as well as an increase in the size
and mass of organs and tissues. In addition, it in£uences
protein, carbohydrate, and lipid metabolism. A unique pecu-
liarity of human and primate growth hormones (GHs) is the
broad species speci¢city and the capability of a direct e¡ect on
the mammary gland cells by increasing RNA and protein syn-
thesis (lactogenic activity) [1]. Practically all of the recombi-
nant hGH produced by bacteria at high temperature (37‡C) is
localized in large insoluble aggregates, the so-called inclusion
bodies [2], which pose a serious obstacle to e⁄cient hGH
production for biomedical use. One of the ways of solving
the problem of hGH aggregation in vivo is to increase its
intrinsic stability so as to compensate for the lack of disul¢de
bonds in bacterial cytoplasm.
Numerous e¡ects caused by hGH are based on its ability to
bind to speci¢c receptors on the target cell surfaces. Evidently,
the hGH binding interfaces have evolved to make favorable
intermolecular contacts with the receptors. This may be at the
expense of intramolecular interactions and burying hydropho-
bic residues, and so lower the hGH conformational stability
[3]. Indeed, there are many examples showing that the replace-
ment of the ligand binding residues results in increased pro-
tein stability [4,5]. Then, attenuation of one of the hGH minor
activities might lead to a stabilization of its structure. To
check such a possibility, we have constructed a series of chi-
meric GHs with homologous replacements in hGH based on
the structure of porcine growth hormone (pGH). Since the
latter is devoid of lactogenic activity, we expect that the ac-
tivity will be lost in some of the chimeric hormones. The
primary structures of human and porcine GHs are highly
homologous (67%) and their tertiary structures are similar.
Therefore, it may be anticipated that the mutations intro-
duced into the hGH molecule will not signi¢cantly change
its conformation. This work reports a study of lactogenic
activity and stability of chimeric hormones ‘14^33’, ‘41^73’,
‘14^95’, and ‘78^95’. Figures designating chimeric GHs corre-
spond to the residues from the pGH sequence that are in-
serted into hGH; the numbering follows the hGH sequence.
In accordance with this, variant ‘14^33’ is a hGH in which the
region £anked by residues 14 and 33 is replaced with a similar
region of pGH. We show that the elimination of lactogenic
activity results in stabilization of hGH molecule and that in-
tracellular hormone solubility is determined by its stability.
2. Material and methods
2.1. Gene expression and protein puri¢cation
Genes for chimeric GHs were constructed by the ‘homolog recom-
bination’ method [6]. The nucleotide sequences of GHs genes were
determined in both directions. Expression plasmids for GHs were
constructed by replacement of gene 10 in pGEMEX1 (Promega)
with a GH gene [2]. Proteins were puri¢ed from the Escherichia coli
strain BL21(DE3) harboring the corresponding expression plasmid [7].
2.2. Nb2-11C cell proliferation assay
Synchronization of Nb2-11C cells in the G0/G1 phase and monitor-
ing of cell proliferation were performed as described earlier [8]. The
doubling rates were calculated after 72 h from the following equation:
No. of doublings= log [(no. of cells in the presence of a hormone)/(no.
of cells in the absence of a hormone)]/log2. The initial number of cells/
ml was 250 000.
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2.3. Di¡erential scanning calorimetry (DSC)
Microcalorimetric measurements were carried out on a DASM-4
microcalorimeter (NPO Biopribor, Pushchino, Russia) in 0.48 ml cells
at a heating rate of 1 K/min on 0.4^0.8 mg/ml proteins in 10 mM
Na2HPO4, pH 7.5. The partial molar heat capacity of the protein
(Cp), denaturation temperature (Td) and calorimetric denaturation
enthalpy (vHcal) were determined as described elsewhere [9]. The ac-
curacy of the calorimetric enthalpy was 6%, that of Td within 0.2‡C.
2.4. Circular dichroism (CD)
Far-UV CD spectra were recorded on a Jasco J-715 spectropo-
larimeter equipped with Neslab RTE-111 water bath in a 0.02 cm
cell on 0.3 mg/ml proteins in 10 mM Na2HPO4, pH 7.5. Protein
melting was carried out at the same heating rate as in microcalorim-
etry (1 K/min). Denaturation temperatures were determined from the
peaks in the ¢rst derivatives of the melting pro¢les (accuracy 0.3‡C).
The results were expressed as molar ellipticity, [3] (deg cm2 dmol31),
based on a mean amino acid residue weight of 115.7 for hGH, 113.1
for variant ‘14^95’, 115.1 for variant ‘14^33’, 114.3 for variant ‘41^73’
and 115.5 for variant ‘78^95’.
2.5. Equilibrium guanidine hydrochloride (GdnHCl)-induced
denaturation
Denaturation experiments were performed at 25‡C in 10 mM
Na2HPO4, pH 7.5, at a ¢nal protein concentration of 0.2 mg/ml.
The GdnHCl concentrations were determined by refractometry. The
unfolding transition was monitored by CD at 222 nm.
3. Results and discussion
3.1. hGH and chimeric GHs lactogenic activity
Lactogenic activity of GHs was determined by an increase
in the amount of preliminarily synchronized cells of the rat
lymphoma line Nb2-11C in response to the preparation under
study. Hormones devoid of lactogenic activity are not able to
stimulate proliferation of this cell line [10]. The results of
measurements of proliferative activity are shown in Fig. 1.
It is seen that activity of GHs ‘14^33’ and ‘78^95’ do not
di¡er from that of hGH. The ‘14^95’ GH is devoid of ability
to stimulate cell proliferation in the whole interval of concen-
trations from 0 to 500 pM. The ‘41^73’ GH activity is mark-
edly decreased. Thus, cells begin to proliferate only at the
hormone concentration of 8 pM (such a ‘threshold’ concen-
tration for hGH is 0.2 pM), whereas cell doubling in 72 h is
observed at the ‘41^73’ GH concentration of 440 pM (and at
2 pM hGH). It is quite obvious that such a drastic decrease in
the hormone activity is due to mutations in the 41^73 region.
The ‘14^33’ variant is equipotent to hGH in Nb2-11C bio-
assay (Fig. 1). Moreover, substitution of the segment 8^19 in
hGH for homologous segment derived from pGH a¡ects nei-
ther the proliferative activity in Nb2-11C bioassay, nor the
binding a⁄nity for the Nb2 prolactin receptors [8]. Thus,
the homologous substitutions in the hGH segment 8^33 do
not in£uence the hGH binding to Nb2 rat prolactin receptors.
In contrast, according to [11], the hGH mutant containing
segment 11^33 of pGH causes tremendous disruption in bind-
ing a⁄nity for the human prolactin receptor. Similarly, intro-
duction of Lys168Ala/Glu174Ala mutations into hGH caused
more than 6000 times decrease in its activity in the test of
FDC-P1 cells transfected with the full-length human prolactin
receptor and only 12 times decrease in the Nb2-11C test if the
half-maximal concentrations for stimulation of cell prolifera-
tion (EC50) were compared [12]. Altogether, this suggests that
the functional determinants for the hGH binding to the hu-
man and rat prolactin receptors do not coincide. The com-
plete loss of the ‘14^95’ GH activity and preservation of that
of ‘14^33’ and ‘78^95’ GHs in the rat lymphoma Nb2 test
mean that the region 34^77 contains amino acid residues
that are critical for the interaction of hGH with the rat pro-
lactin receptors.
3.2. Secondary structure and thermostability of hGH and
chimeric hormones
To study conformational changes in chimeric proteins, CD
in the far-UV region was used. The CD spectrum of hGH
(Fig. 2) is typical of a protein with a high content of K-helices
and coincides with the previously published data [13]. All
spectra of hybrid proteins are practically identical in shape
Fig. 1. The e¡ect of various concentrations of hGH (E) or chimeric
GHs ‘14^95’ (a), ‘14^33’ (O), ‘41^73’ (S) and ‘78^95’ (8) on the
proliferation rate of Nb2-11C lymphoma cells.
Fig. 2. CD spectra of hGH (double chain line ^ 20‡C, triple chain
line ^ 90‡C) and chimeric GHs ‘14^33’ (solid line), ‘14^95’ (dotted
line), ‘41^73’ (dashed line) and ‘78^95’ (chain line) at pH 7.5, 20‡C.
Inset: Temperature dependence of CD at 222 nm for hGH (1) and
chimeric GH ‘14^33’ (2).
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to that of hGH. However, the spectral amplitudes in charac-
teristic minima and maximum are di¡erent, i.e. chimeric hor-
mones and hGH are characterized by a di¡erent helical con-
tent (Table 1).
The e¡ect of mutations on the parameters characterizing
the thermal denaturation of the hormone was studied using
DSC. Fig. 3 shows the temperature dependence of the excess
heat capacity of hGH and chimeric hormones at pH 7.5. In all
cases denaturation was irreversible. Partial heat capacities of
hGH and hybrids at 25‡C are the same and equal to
(0.34V 0.02) cal/KWg. This value is typical of compact globular
proteins [9]. The calorimetric enthalpy of hGH denaturation
(Fig. 3, curve 1) is 48 kcal/mol that is more than two times
lower than mean values of denaturation enthalpy correspond-
ing to full unfolding of the near-size proteins [9]. A similar
result was obtained for hGH in the acid pH interval [14]. The
midpoint of the hGH thermal denaturation was equal to
81‡C. For GHs ‘41^73’, ‘14^95’ and ‘14^33’, denaturation
temperature increases for 2.7, 4.0 and 8.3‡C, respectively,
whereas for ‘78^95’ it decreases for 6‡C (Table 1).
To collate the thermodynamic and structural data for hGH
and ‘14^95’, the temperature dependence of the CD at 222 nm
was measured. hGH undergoes a cooperative transition at
81.2‡C, whereas it occurs at 86.6‡C for ‘14^95’ (Fig. 2, inset).
These values are very close to the corresponding Td values
obtained using scanning microcalorimetry. The CD amplitude
for hGH at 90‡C made up about 50% of initial level (Fig. 2).
Similar results were obtained in [14] at acid pH. This is in-
dicative of preservation of a signi¢cant part of secondary
structure in the denatured protein and supports calorimetric
data also pointing to a partial unfolding of hGH during heat
denaturation due to aggregation.
3.3. Equilibrium denaturation of hGH and chimeric hormones
by GdnHCl
The GdnHCl denaturation of GHs was extensively studied
[15^17]. Non-human species of GH were characterized by the
presence of the unfolding intermediates having a tendency to
self-associate. At low protein concentrations (9 0.2 mg/ml),
the hGH denaturation, studied by various techniques, was
shown to be completely reversible and consistent with the
two-state mechanism. However, at higher protein concentra-
tions there is the e¡ect of protein concentration on the free
energy of unfolding due to the presence of self-associating
unfolding intermediates [18].
The GdnHCl denaturation data for hGH and chimeric hor-
mones are presented in Fig. 4. The S-shaped dependences of
CD intensities on GdnHCl at 222 nm are indicative of a
highly cooperative melting process [9]. Mutations in hGH
resulted in an increase of the GdnHCl concentration at 50%
protein unfolding (D50%) for GHs ‘14^33’ and ‘14^95’ (Table
1).
3.4. Relationship between inclusion bodies formation in E. coli
cells and GHs stability
It is well known that the reducing milieu of bacterial cyto-
plasm prevents disul¢de bond formation in proteins [19]. At
the same time, reduction of disul¢de bridges in hGH signi¢-
cantly lowers its stability and results in an increased tendency
for self-association as compared with the disul¢de-containing
hGH molecules [20]. This may have relevance for the forma-
tion of inclusion bodies during the heterologous expression of
hGH gene in E. coli.
Table 1
Content of K-helices, temperature of heat denaturation and GdnHCl
concentration at D50% for hGH and chimeric hormones at pH 7.5
Hormone fHa Td (‡C)b D50% (M)c
‘14^33’ 0.66 89.3 4.77
‘14^95’ 0.60 85.0 4.85
‘41^73’ 0.58 83.7 4.54
hGH 0.56 81.0 4.54
‘78^95’ 0.52 75.0 4.33
aCalculation of K-helix content (fH) was based on equation fH =
3([3]222+2340)/30 300 [21]. The estimated uncertainty is 3%.
bThe estimated uncertainty is 0.2‡C.
cThe estimated uncertainty is 1%.
Fig. 3. Temperature dependence of the excess heat capacity of hGH
(1) and chimeric GHs ‘78^95’ (2), ‘41^73’ (3), ‘14^95’ (4) and
‘14^33’ (5) at pH 7.5.
Fig. 4. The GdnHCl-induced equilibrium denaturation of hGH
(F, solid line) and chimeric GHs ‘78^95’ (8, dotted line), ‘41^73’
(S, dashed line), ‘14^33’ (R, chain line) and ‘14^95’ (b, double
chain line) at 25‡C, pH 7.5, as detected by CD at 222 nm. Protein
concentration was 0.2 mg/ml.
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We compared the tendency of the wild-type and chimeric
GHs to form inclusion bodies in bacteria. Soluble and total
cellular fractions were prepared and analyzed by SDS^PAGE
(Table 2). All the proteins were produced at the same level
(about 300 mg/l). At 37‡C about 95% hGH is localized within
a cell as insoluble aggregates. As growth temperature de-
creases, a soluble protein fraction is increased, and at 24‡C
hGH is mainly accumulated in a soluble form in the cyto-
plasm. On the contrary, pGH is found in inclusion bodies
in the whole temperature interval from 37 to 9‡C (data not
shown). Substitutions in the region 14^95 as a rule improve
intracellular solubility of hGH. Thus, already at 30‡C (vs.
24‡C for hGH) chimeric GHs ‘14^33’ and ‘41^73’ are detect-
able mainly in a soluble fraction. ‘14^95’ GH is fully soluble
even at 37‡C. Moreover, about 20% of this protein is soluble
even at 42‡C. This markedly distinguishes it both from hGH
and pGH. ‘78^95’ GH resembles hGH by its properties.
The comparison of intracellular solubility of chimeric hor-
mones and corresponding values of D50% reveals a regularity ^
the more resistant the protein to GdnHCl denaturation, the
higher its solubility. The most stable variant, ‘14^95’ GH
(Table 1), has the highest solubility in the series of the hor-
mones studied (Table 2), and the least stable hormones, ‘78^
95’ GH and hGH, have the lowest solubility (only 20% of ‘78^
95’ GH and 25% of hGH are soluble at 30‡C). ‘14^33’ GH
with intermediate value of D50% was found entirely in the
soluble fraction at 30‡C. A similar relationship between the
protein solubility and its stability was found for a single chain
antibody fragment [19].
The cytoplasmic expression is preferable for protein pro-
duction because it provides maximal product yield. The
main obstacle to this route is the protein deposition in inclu-
sion bodies as an insoluble and inactive material. The data
described in this work demonstrate the possibility to increase
intracellular solubility of a protein by increasing its intrinsic
stability.
3.5. Elimination of lactogenic activity results in stabilization of
hGH
Our results indicate an inverse relationship between the
lactogenic activity of hGH and its stability. Demolishing lac-
togenic activity made it possible to construct the hGH var-
iants (‘41^73’ and ‘14^95’) exhibiting higher conformational
stability and lower propensity to form inclusion bodies in
bacterial cytoplasm. At the ¢rst glance, the mutant ‘14^33’
is an exception to the rule. Being most stable to the thermal
denaturation it is equipotent to hGH in bioactivity deter-
mined in Nb2 test. But it appears to be the exception that
proves the rule. Really, as was discussed above, the functional
hGH determinants for binding to the human and rat prolactin
receptors do not coincide completely. The homologous sub-
stitution of the segment 11^33 in hGH for porcine segment
causes dramatic decrease in binding a⁄nity for the human
prolactin receptor [11]. Thus, although the variant ‘14^33’ is
fully active in the Nb2-lymphoma bioassay, it most likely
lacks the lactogenic potency in humans.
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